Evidence map›Paper›PMID 39439009›Full record

ArticleImplementation science communications2024

Champions to enhance implementation of clinical and community-based interventions in cancer: a scoping review.

Joseph Astorino Nicola, M Muska Nataliansyah, Maria A Lopez-Olivo, Adebola Adegboyega, Kelly A Hirko, Lou-Anne R Chichester, Nora L Nock, Pamela Ginex, Shannon M Christy, Paul Levett

Abstract readScoping Review
In one paragraph

Article in Implementation science communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Development and Evaluation of an HPV Vaccine Champion Training: a Strategy to Boost Adolescent Vaccination in Community Health Centers in Florida.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joseph Astorino NicolaDepartment of Sociology, Washington State University, 310 NW Joe Street, Pullman, WA, 99163, USA. joseph_astorino@wsu.edu.
M Muska NataliansyahDepartment of Surgery, Division of Surgical Oncology, Collaborative for Healthcare Delivery Science, Medical College of Wisconsin, Milwaukee, WI, USA.
Maria A Lopez-OlivoDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Adebola AdegboyegaUniversity of Kentucky College of Nursing, Lexington, KY, USA.
Kelly A HirkoDepartment of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Lou-Anne R ChichesterMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Nora L NockDepartment of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Pamela GinexSchool of Nursing, Stony Brook University, Stony Brook, NY, USA.
Shannon M ChristyDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
Paul LevettSchool of Medicine, George Washington University, Washington, DC, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibitionK08CA237619 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOPEZ-OLIVO, MARIA DE LOS ANGELES · 2020 to 2024
$938k
NCI NIH HHS CA237619NCI NIH HHS K08 CA237619NCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748).
6 · The paper itself

Abstract

backgroundChampions are integral across research in cancer, yet studies exploring their roles are limited and have produced mixed results. The current review examines and synthesizes descriptions of how champions emerged and the types of activities they most often performed. By examining evidence from across the translational research continuum, this scoping review aims to characterize the role of champions and strategies that facilitate their involvement in the implementation of cancer care interventions in both clinical and community-based settings.

methodsThis scoping review was designed and implemented in compliance with PRISMA-ScR. The review focused on peer-reviewed articles in English-language journals. We searched five databases: PubMed (including MEDLINE), Scopus (including EMBASE), CINAHL, PsycINFO, and the Cochrane Library. Articles published from 1971 to 2022 were included. Two members of the team reviewed in duplicate each article and then a single member of the team extracted the data in Covidence, with a second member comparing the extraction to the original article. Qualitative and quantitative data were extracted and then synthesized. These data were used to summarize core champion activities and implementation strategies and to characterize barriers and facilitators to using champions in research.

resultsA total of 74 articles were included in the review. The qualitative synthesis highlighted facilitators and barriers to the effective use of champions. Facilitators included consideration of an individual's characteristics when identifying champions, time spent planning for the specific responsibilities of champions, working within a supportive environment, and identifying champions embedded in the target setting. Major barriers included constrained time, low self-efficacy among champions, inadequate training, high turnover rates of champions, and a lack of buy-in from organizational leadership toward the intervention. Champions also were mostly assigned their roles, had varied core activities, and used complementary strategies to empower their target populations. Champions' most frequent core activities include facilitation, outreach/promotion, and recruitment of participants into studies.

conclusionsChampions were used in research of many cancer types and often serve similar roles regardless of where they are located within the translational research process. Despite their critical role, evidence is lacking on the impact of champions specifically on outcomes of many of the research studies that include them. Future research is needed to understand the nuances of champion-driven approaches across diverse cancer care settings.

Indexed as

CancerChampionChange agentClinical championCommunity championFacilitationImplementation leaderImplementation scienceImplementation strategyOutreachPromotion

Identifiers

PMID39439009
PMCPMC11494796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.